Comparative activity of biodegradable nanoparticles with aluminum adjuvants: Antigen uptake by dendritic cells and induction of immune response in mice

Immunology Letters

Volumn 140, Issue 1-2, 2011, Pages 36-43

  Uto, Tomofumi ^a,c   Akagi, Takami ^b,c   Toyama, Masaaki ^a,c   Nishi, Yosuke ^a,c   Shima, Fumiaki ^b,c   Akashi, Mitsuru ^b,c   Baba, Masanori ^a,c  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Adaptive immunity; Adjuvant; Dendritic cell; Nanoparticle; Vaccine

Indexed keywords

3 O DESACYL 4' MONOPHOSPHORYL LIPID A; ALUMINUM; GLUTAMIC ACID; IMMUNOGLOBULIN G; IMMUNOLOGICAL ADJUVANT; NANOPARTICLE; OVALBUMIN; PHOSPHORYL LIPID A; POLY(GAMMA GLUTAMIC ACID); UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN SPECIFICITY; ANTIGENIC MODULATION; ARTICLE; BIODEGRADABILITY; CD8+ T LYMPHOCYTE; CELLULAR DISTRIBUTION; COMPARATIVE STUDY; CONTROLLED STUDY; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SPACE; LYSOSOME; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PHAGOCYTOSIS; PINOCYTOSIS; PRIORITY JOURNAL;

ABSORBABLE IMPLANTS; ADJUVANTS, IMMUNOLOGIC; ALUMINUM; ANIMALS; ANTIGENS; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; DENDRITIC CELLS; ENDOCYTOSIS; FEMALE; IMMUNITY, CELLULAR; IMMUNIZATION; MICE; MICE, INBRED C57BL; NANOPARTICLES; OVALBUMIN; POLYGLUTAMIC ACID;

EID: 80051784705     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2011.06.002     Document Type: Article

References (23)

1. Pashine A., Valiante N.M., Ulmer J.B. Targeting the innate response with improved vaccine adjuvants. Nat Med 2005, 11:S63-68.
2. Plotkin S.A. Vaccines: past, present and future. Nat Med 2005, 11:S5-11.
3. Garcon N., Chomez P., Mechelen M.V. Glaxosmithkline adjuvant systems in vaccines: concepts, achievements and perspectives. Expert Rev Vaccines 2007, 6:723-739.
4. Qureshi N., Takayama K., Ribi E. Purification and structural determination of nontoxic lipid A obtained from the lipopolysaccharide of salmonella typhimurium. J Biol Chem 1982, 257:11808-11815.
5. Hirschfeld M., Ma Y., Weis J.H., Vogel S.N., Weis J.J. Repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2. J Immunol 2000, 165:618-622.
6. Evans J.T., Cluff C.W., Johnson D.A., Lacy M.J., Persing D.H., Baldridge J.R. Enhancement of antigen-specific immunity via the TLR4 ligands MPL adjuvant and Ribi.529. Expert Rev Vaccines 2003, 2:219-229.
7. Petrovsky N., Aguilar J.C. Vaccine adjuvants: current state and future trends. Immunol Cell Biol 2004, 82:488-496.
8. Jordan M.B., Mills D.M., Kappler J., Marrack P., Cambier J.C. Promotion of B cell immune responses via an alum-induced myeloid cell population. Science 2004, 304:1808-1810.
9. Akira S., Takeda K., Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2001, 2:675-680.
10. Kawai T., Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 2010, 11:373-384.
11. Banchereau J., Briere F., Caux C., Davoust J., Lebecque S., Liu Y.J., et al. Immunobiology of dendritic cells. Annu Rev Immunol 2000, 18:767-811.
12. Sato K., Fujita S. Dendritic cells: nature and classification. Allergol Int 2007, 56:183-191.
13. Uto T., Wang X., Sato K., Haraguchi M., Akagi T., Akashi M., et al. Targeting of antigen to dendritic cells with poly(γ-glutamic acid) nanoparticles induces antigen-specific humoral and cellular immunity. J Immunol 2007, 178:2979-2986.
14. Himeno A., Akagi T., Uto T., Wang X., Baba M., Ibuki K., et al. Evaluation of the immune response and protective effects of rhesus macaques vaccinated with biodegradable nanoparticles carrying gp120 of human immunodeficiency virus. Vaccine 2010, 28:5377-5385.
15. Wang X., Uto T., Akagi T., Akashi M., Baba M. Induction of potent CD8+ T-cell responses by novel biodegradable nanoparticles carrying human immunodeficiency virus type 1 gp120. J Virol 2007, 81:10009-10016.
16. Akagi T., Wang X., Uto T., Baba M., Akashi M. Protein direct delivery to dendritic cells using nanoparticles based on amphiphilic poly(amino acid) derivatives. Biomater 2007, 28:3427-3436.
17. Okamoto S., Matsuura M., Akagi T., Akashi M., Tanimoto T., Ishikawa T., et al. Poly(γ-glutamic acid) nanoparticles combined with mucosal influenza virus hemagglutinin vaccine protects against influenza virus infection in mice. Vaccine 2009, 27:5896-5905.
18. Eidsmo L., Allan R., Caminschi I., Rooijen N.V., Heath W.R., Carbone F.R. Differential migration of epidermal and dermal dendritic cells during skin infection. J Immunol 2009, 182:3165-3172.
19. Didierlaurent A.M., Morel S., Lockman L., Giannini S.L., Bisteau M., Carlsen H., et al. AS04, an aluminum sail- and TLR4 agonist-based adjuvant system, induces a transient localized innate immune response leading to enhanced adaptive immunity. J Immunol 2009, 183:6186-6197.
20. Koyama S., Coban C., Aoshi T., Horii T., Akira S., Ishii K.J. Innate immune control of nucleic acid-based vaccine immunogenicity. Expert Rev Vaccines 2009, 8:1099-1107.
21. Yamaguchi S., Tatsumi T., Takehara T., Sasakawa A., Yamamoto M., Kohga K., et al. EphA2-derived peptide vaccine with amphiphilic poly(γ-glutamic acid) nanoparticles elicits an anti-tumor effect against mouse liver tumor. Cancer Immunol Immunother 2010, 59:759-767.
22. Uto T., Wang X., Akagi T., Zenkyu R., Akashi M., Baba M. Improvement of adaptive immunity by antigen-carrying biodegradable nanoparticles. Biochem Biophys Res Commun 2009, 379:600-604.
23. Uto T., Akagi T., Hamasaki T., Akashi M., Baba M. Modulation of innate and adaptive immunity by biodegradable nanoparticles. Immunol Lett 2009, 125:46-52.